Related Experiment Video
Updated: Aug 7, 2026
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
[Global therapeutic approach of muscle dysfunction in COPD]
1Servicio de Endocrinologia y Nutrición, Unidad de Nutrición Clínica y Dietética, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid. julia.alvarez@telefonica.net
Nutricion Hospitalaria
|June 14, 2006
Summary
Muscle mass, not just weight, predicts survival in chronic obstructive pulmonary disease (COPD). Integrated therapeutic strategies are crucial for managing COPD patients and improving their outcomes.
Area of Science:
- Pulmonary Medicine
- Clinical Nutrition
- Muscle Physiology
Context:
- Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition with increasing prevalence and significant healthcare costs.
- Hyponutrition and muscle dysfunction are key factors influencing COPD severity and patient prognosis.
- Muscle mass is a more accurate predictor of survival than body weight in moderate to severe COPD patients.
Purpose:
- To highlight the critical role of muscle mass in COPD prognosis.
- To discuss the multifactorial development of hyponutrition and muscle deterioration in COPD.
- To advocate for integrated therapeutic strategies to combat muscle wasting in COPD.
Summary:
- Muscle wasting and hyponutrition significantly impact COPD severity and mortality.
- Multidisciplinary care, including nutritional support and pulmonary rehabilitation, is essential for COPD management.
- Pulmonary rehabilitation programs should incorporate physical training, psychosocial support, education, and nutritional interventions.
Impact:
- Emphasizes the importance of assessing and maintaining muscle mass in COPD patients.
- Promotes a holistic, multidisciplinary approach to COPD care.
- Provides a framework for developing effective interventions to improve physical and social autonomy in COPD patients.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...